Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration

OBJECTIVE: To analyze the characteristics of gastrointestinal bleeding secondary to high-dose melphalan pretreatment in patients with multiple myeloma. METHODS: Between 1 January 2016 and 31 October 2021, 26 patients with multiple myeloma after autologous peripheral blood hematopoietic stem cell tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Qunfang, Wang, Yi, Zhu, Huiling, Xu, Kaihong, Sheng, Lixia, Yan, Xiaoyan, Ouyang, Guifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293567/
https://www.ncbi.nlm.nih.gov/pubmed/35860001
http://dx.doi.org/10.1155/2022/2088217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293567/
https://www.ncbi.nlm.nih.gov/pubmed/35860001
http://dx.doi.org/10.1155/2022/2088217

Ejemplares similares